L
LatchBio
Builds and disseminates free to use data infrastructure for the the biocomputing revolution
About LatchBio
Latch.bio is a cloud-based platform that provides a comprehensive solution for biotech companies to manage and analyze their data. It serves hundreds of biotech firms, helping them accelerate their research and development (R&D) milestones by making data analysis faster, cheaper, and more accessible.
The platform offers a range of features including data storage, organization, transformation, and analysis. It allows companies to store unlimited amounts of raw data, eliminating data silos and boosting collaboration. The platform also provides a simple interface for exploring analysis results, making it easier for scientists to make quick decisions on their experiments.
Latch.bio also offers a customizable data platform, giving companies control and flexibility over their data while eliminating the time and cost of infrastructure setup. It also provides mission-critical security, ensuring the safe processing of data at an extreme scale for data storage or bioinformatics workflows.
The business model of Latch.bio is based on providing a one-stop solution for all data needs of biotech companies, replacing multiple platforms at a fraction of the cost. It makes money by charging these companies for using its platform.
In addition, Latch.bio offers features for workflow orchestration. Companies can set up workflows in minutes and scale them to thousands of cores. They can also control their own analysis and run workflows through a simple user interface. This helps save on cloud costs by automatically running on optimized instances.
In summary, Latch.bio is a flexible and secure platform that helps biotech companies accelerate their R&D milestones by making data analysis faster, cheaper, and more accessible.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- San Francisco, United States
- Employees
- 41
- Open positions
- 9
- Dealroom signal
- 95.1/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Synthetic Biology, Sustainable Development Goals, Tech for Biotech and Pharma, Biotech and Pharma, Climate Tech, Techbio, Techbio Drug Discovery, Digital Pharma
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Apr 2026 | $130M | $500M | Undisclosed | ↗ |
| SERIES AOther financing | Jun 2022 | $28M | $112M | Haystack · Caffeinated Capital · Lux Capital · Hummingbird Ventures | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for LatchBio is 29K monthly website visits, up 81.3% over the last three months. LatchBio's team grew 173.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
Swift Ventures
Lux Capital
General Catalyst
Haystack
Alec Nielsen
Fifty Years
Series A3 investors entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about LatchBio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LatchBio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










